Hence, in a coculture system of RA CD25− and CD25high T cells, the apparent restoration of CD25high Treg cell suppressive activity following infliximab treatment was an artifact due to increased percentage of suppressive FoxP3+ cells among the CD25− fraction. The gene discussed is FOXP3; the disease is rheumatoid arthritis.